Effectiveness and Safety of Drugs for Children
A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Global Pediatric Health".
Deadline for manuscript submissions: closed (10 May 2024) | Viewed by 9462
Special Issue Editors
2. Drug Safety Center, Leipzig University and University Hospital, Brüderstraße 32, 04103 Leipzig, Germany
Interests: pediatric pharmacy
2. Drug Safety Center, Leipzig University and University Hospital, Brüderstraße 32, 04103 Leipzig, Germany
Interests: pharmacy; drug safety
2. Division of Neuropediatrics, University Hospital for Children and Adolescents, Fleischmannstr. 8, 17475 Greifswald, Germany
Interests: neuropediatrics; drug safety
Special Issue Information
Dear Colleagues,
Patient safety in drug therapy for children and adolescents is a major challenge for all the health care professionals involved. Drugs used in children and adolescents should be effective, safe, and approved for this patient population. However, pediatric patients are not adequately represented in clinical trials, so off-label use in pediatrics is common. Additionally, studies on the effectiveness and safety of drug use in the routine clinical care of children and adolescents are often lacking. Furthermore, numerous other factors can affect drug therapy, particularly in children and adolescents, such as a lack of appropriate dosage forms, individualized dose calculations, and inadequate information about dosing in children and adolescents. Overall, this can jeopardize the success of drug therapy and lead to avoidable adverse drug events.
This Special Issue welcomes contributions that address drug effectiveness and safety in routine pediatric care to improve drug therapy in pediatric patients.
Dr. Martina Patrizia Neininger
Prof. Dr. Thilo Bertsche
Prof. Dr. Astrid Bertsche
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- safety
- effectiveness
- pediatrics
- routine care
- adverse drug events
- drug therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.